Catalogue
Rabbit anti Human Lysophospholipid Phosphatase (LPP) 2
Catalog number: X1528PIsotype | IgG |
Product Type |
Polyclonal Antibody |
Units | 100 µg |
Host | Rabbit |
Species Reactivity |
Human |
Application |
Western Blotting |
Background
Phosphatidic acid phosphatase type 2 (PAP2) was originally identified as a plasma membrane enzyme that catalyses the dephosphorylation of the putative second messenger, phosphatidic acid (PA) to diacylglycerol (DG) [1]. Subsequently, multiple isoforms of PAP2 were cloned [2-5]. It was found that these enzymes dephosphorylate a number of lipid phosphates in vitro other than PA, including the potent bioactive lipids, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Therefore, they have been renamed lipid phosphate phosphatases (LPPs). Currently, there are four members of this family called LPP1, LPP1a, LPP2 and LPP3 [6]. S1P [7] and LPA [8] regulate the proliferation, differentiation, apoptosis and migration of cells by binding to a family of G protein-coupled receptors. Thus, EDG1/S1P1, EDG3/S1P3, EDG5/S1P2/AGR16/H218, EDG6/S1P4 and EDG8/S1P5/nrg-1 are high affinity S1P receptors [7] whereas EDG2/LPA1, EDG4/LPA2 and EDG7/LPA3 have high affinity for LPA [8]. Recently, the over-expression of LPP1 was shown to limit LPA-stimulated signalling in Rat2 fibroblasts [9] and LPA-stimulated DNA synthesis in HEK 293 cells [10]. Similarly, over-expression of LPP1, LPP1a and LPP2 attenuate S1P-signalling to the p42/p44 mitogen activated protein kinase cascade [11].
Synonyms: Lipid phosphate phosphohydrolase 2, EC 3.1.3.4, Phosphatidic acid, phosphatase 2c, PAP-2c, PAP2c, Phosphatidate phosphohydrolase type 2c, PAP2-gamma, PAP2-G
Source
Rabbits were immunized with a unique peptide derived from the human lysophospholipid phosphatase 2 protein.
Product
Provided as solution in phosphate buffered saline with 0.08% sodium azide
Product Form: Unconjugated
Purification Method: Ammonium Sulfate Precipitation
Concentration: See vial for concentration
Applications
This antibody can be used for Western blotting (10-15 µg/ml). Optimal concentration should be evaluated by serial dilutions. NOTE: Boiling LPP2 with sample buffer will aggregate the protein. Lysates should be prepared by mixing cells with lysis buffer (possibly with extra detergent) to solubilize the protein before adding sample buffer and lysate SHOULD NOT be boiled/heated.
Functional Analysis: Western Blotting
Positive Control: Transfected HEK-293 cells
Storage
Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
Product Stability: See expiration date on vial
Shipping Conditions: Ship at ambient temperature, freeze upon arrival
Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.
References
1. Jamal, Z., et al. (1991) Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J. Biol. Chem. 266, 2988-2996.
2. Kai, M., et al. (1997) Cloning and characterisation of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J. Biol. Chem. 272, 24572-24578.
3. Roberts, R., et al. (1998) Human type 2 phosphatidic phosphohydrolases. Substrate specificity of the type 2a, 2b and 2c enzymes and cell surface activity of the 2a isoforms. J. Biol. Chem. 273, 22059-22067.
4. Leung, D.W., et al. (1998) Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells. DNA Cell. Biol. 17, 377-385.
5. Tate, R.J., et al. (1999) Molecular cloning of magnesium-independent type 2 phosphatidic acid phosphatases from airway smooth muscle. Cell. Signal. 11, 515-522.
6. Brindley, D.N & Waggoner, D.W. (1998) Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273, 24281-24284.
7. Pyne, S. & Pyne, N.J. (2000) Sphingosine 1-phosphate in mammalian cells. Biochem. J. 349, 385-402.
8. Kranenberg, O. & Moolenaar, W.H. (2001) Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 20 1540-1546.
9. Xu, J., et al. (2000) Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate through EDG-2 receptors. J. Biol. Chem. 275, 27520-27530.
10. Hooks, S.B., et al. (2001) Lysophosphatidic acid induced mitogenesis is regulated by lipid phosphate phosphatases and is EDG receptor independent. J. Biol. Chem. 276, 4611-4621.
11. Alderton, F., et al. (2001) J. Biol. Chem. 276, 13452-13460.
Protein Reference(s)
Database Name: UniProt
Accession Number: O43688 (Human)
Species Accession: Human
Safety Datasheet(s) for this product:
NM_Sodium Azide |
" Western blot analysis using LPP2 antibody on vector-controlled HEK-293 cells (V) and HEK-293 cells overexpressing LPP2 protein (2) at 1 µg/ml" |
" Western blot analysis using LPP2 antibody on vector-controlled HEK-293 cells (V) and HEK-293 cells overexpressing LPP2 protein (2) at 1 µg/ml"